Cargando…

What SARS-CoV-2 does to our brains

Neurological symptoms in SARS-CoV-2-infected patients have been reported, but their cause remains unclear. In theory, the neurological symptoms observed after SARS-CoV-2 infection could be (1) directly caused by the virus infecting brain cells, (2) indirectly by our body’s local or systemic immune r...

Descripción completa

Detalles Bibliográficos
Autores principales: Aschman, Tom, Mothes, Ronja, Heppner, Frank L., Radbruch, Helena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212726/
https://www.ncbi.nlm.nih.gov/pubmed/35777361
http://dx.doi.org/10.1016/j.immuni.2022.06.013
_version_ 1784730670603436032
author Aschman, Tom
Mothes, Ronja
Heppner, Frank L.
Radbruch, Helena
author_facet Aschman, Tom
Mothes, Ronja
Heppner, Frank L.
Radbruch, Helena
author_sort Aschman, Tom
collection PubMed
description Neurological symptoms in SARS-CoV-2-infected patients have been reported, but their cause remains unclear. In theory, the neurological symptoms observed after SARS-CoV-2 infection could be (1) directly caused by the virus infecting brain cells, (2) indirectly by our body’s local or systemic immune response toward the virus, (3) by coincidental phenomena, or (4) a combination of these factors. As indisputable evidence of intact and replicating SARS-CoV-2 particles in the central nervous system (CNS) is currently lacking, we suggest focusing on the host’s immune reaction when trying to understand the neurocognitive symptoms associated with SARS-CoV-2 infection. In this perspective, we discuss the possible immune-mediated mechanisms causing functional or structural CNS alterations during acute infection as well as in the post-infectious context. We also review the available literature on CNS affection in the context of COVID-19 infection, as well as observations from animal studies on the molecular pathways involved in sickness behavior.
format Online
Article
Text
id pubmed-9212726
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-92127262022-06-22 What SARS-CoV-2 does to our brains Aschman, Tom Mothes, Ronja Heppner, Frank L. Radbruch, Helena Immunity Perspective Neurological symptoms in SARS-CoV-2-infected patients have been reported, but their cause remains unclear. In theory, the neurological symptoms observed after SARS-CoV-2 infection could be (1) directly caused by the virus infecting brain cells, (2) indirectly by our body’s local or systemic immune response toward the virus, (3) by coincidental phenomena, or (4) a combination of these factors. As indisputable evidence of intact and replicating SARS-CoV-2 particles in the central nervous system (CNS) is currently lacking, we suggest focusing on the host’s immune reaction when trying to understand the neurocognitive symptoms associated with SARS-CoV-2 infection. In this perspective, we discuss the possible immune-mediated mechanisms causing functional or structural CNS alterations during acute infection as well as in the post-infectious context. We also review the available literature on CNS affection in the context of COVID-19 infection, as well as observations from animal studies on the molecular pathways involved in sickness behavior. Elsevier Inc. 2022-07-12 2022-06-20 /pmc/articles/PMC9212726/ /pubmed/35777361 http://dx.doi.org/10.1016/j.immuni.2022.06.013 Text en © 2022 Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Perspective
Aschman, Tom
Mothes, Ronja
Heppner, Frank L.
Radbruch, Helena
What SARS-CoV-2 does to our brains
title What SARS-CoV-2 does to our brains
title_full What SARS-CoV-2 does to our brains
title_fullStr What SARS-CoV-2 does to our brains
title_full_unstemmed What SARS-CoV-2 does to our brains
title_short What SARS-CoV-2 does to our brains
title_sort what sars-cov-2 does to our brains
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212726/
https://www.ncbi.nlm.nih.gov/pubmed/35777361
http://dx.doi.org/10.1016/j.immuni.2022.06.013
work_keys_str_mv AT aschmantom whatsarscov2doestoourbrains
AT mothesronja whatsarscov2doestoourbrains
AT heppnerfrankl whatsarscov2doestoourbrains
AT radbruchhelena whatsarscov2doestoourbrains